Sidong Huang, Ph.D.
Affiliations: | 2003 | University of California, San Francisco, San Francisco, CA |
Area:
signal transduction, transcriptional regulationGoogle:
"Sidong Huang"Mean distance: 9.64 | S | N | B | C | P |
Parents
Sign in to add mentor| Erin K. O'Shea | grad student | 2003 | UCSF | |
| (Functional and genome-wide analysis of the PHO signaling pathway.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Zhu X, Fu Z, Dutchak K, et al. (2024) Co-targeting CDK4/6 and BRD4 promotes senescence and ferroptosis sensitivity in cancer. Cancer Research |
| Xue Y, Zhu X, Meehan B, et al. (2020) SMARCB1 loss induces druggable cyclin D1 deficiency via upregulation of MIR17HG in atypical teratoid rhabdoid tumors. The Journal of Pathology |
| Tischkowitz M, Huang S, Banerjee S, et al. (2020) Small Cell Carcinoma of the Ovary, Hypercalcaemic Type - genetics, new treatment targets and current management guidelines. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
| Kong T, Xue Y, Cencic R, et al. (2019) eIF4A inhibitors suppress cell cycle feedback response and acquired resistance to CDK4/6 inhibition in cancer. Molecular Cancer Therapeutics |
| Shorstova T, Marques M, Su J, et al. (2019) SWI/SNF-compromised cancers are susceptible to bromodomain inhibitors. Cancer Research |
| Xue Y, Meehan B, Macdonald E, et al. (2019) CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary. Nature Communications. 10: 558 |
| Xue Y, Meehan B, Fu Z, et al. (2019) SMARCA4 loss is synthetic lethal with CDK4/6 inhibition in non-small cell lung cancer. Nature Communications. 10: 557 |
| Rayes RF, Mouhanna JG, Wang C, et al. (2019) Abstract 2799: Targeting CXCR2-mediated neutrophil recruitment to lung cancer Cancer Research. 79: 2799-2799 |
| Karimzadeh M, Jandaghi P, Papadakis AI, et al. (2018) Aberration hubs in protein interaction networks highlight actionable targets in cancer. Oncotarget. 9: 25166-25180 |
| Perron G, Jandaghi P, Solanki S, et al. (2018) A General Framework for Interrogation of mRNA Stability Programs Identifies RNA-Binding Proteins that Govern Cancer Transcriptomes. Cell Reports. 23: 1639-1650 |